TradingView
RocketTickers
2021年10月11日午後5時19分
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic process
NYSE:MYOV
詳細
⋅
2021年10月11日午後5時19分
MYOV: Enzyvant
2021-10-09 20:09:51
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia
Beyond Technical Analysis
詳細